Europe Cancer Diagnostics Market Sees Promising Growth Amid Rising Demand for Precision Diagnostics – Forecasts to 2031
DUBLIN, March 1, 2024 /PRNewswire/ — The “Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), and End User (Hospital, Imaging Center, Pharmaceutical) –
Canadian Investment Regulatory Organization Trade Resumption – NVN.P
VANCOUVER, BC, March 1, 2024 /CNW/ – Trading resumes in: Company: Navion Capital II Inc. TSX-Venture Symbol: NVN.P All Issues: Yes Resumption (ET): 9:30 AM 3/4/2024 CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading h
Canadian Investment Regulatory Organization Trade Resumption – VENI
VANCOUVER, BC, March 1, 2024 /CNW/ – Trading resumes in: Company: Top Strike Resources Corp. CSE Symbol: VENI All Issues: Yes Resumption (ET): 9:30 AM 3/4/2024 CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halt
Notice – RAYMOND POMROY, File No. 2024-3
TORONTO, March 1, 2024 /CNW/ – The Tribunal issued a Notice of Hearing for a hearing to consider whether it is in the public interest to approve the Settlement Agreement entered into by Staff of the Commission and Raymond Pomroy in the above-named matter. The hearing will be held on March 8, 2
Minister Qualtrough announces investments in sport and physical activity opportunities for Indigenous communities
The Government of Canada continues supporting sport and physical activity opportunities for Indigenous communities VICTORIA, BC, March 1, 2024 /CNW/ – The Government of Canada is committed to supporting First Nations, Inuit and Métis communities in building strong and healthy communities thr
The Dallas Opera’s 2024/2025 Season Features Four Classic Titles with Two New-to-Dallas Premieres
DALLAS, March 1, 2024 /PRNewswire/ — Ian Derrer, The Dallas Opera’s Kern Wildenthal General Director and CEO, and Emmanuel Villaume, The Mrs. Eugene McDermott Music Director, announce programming for The Dallas Opera’s 2024/2025 Season. The 67th season of The Dallas Opera (TDO) fea
Global Cancer/Tumor Profiling Market Research Report 2023-2030: Multi-Omics Tumor Profiling Advances Fuel Developments, Rising Personalized Medicine Trends Driving Growth
DUBLIN, March 1, 2024 /PRNewswire/ — The “Cancer/Tumor Profiling Market by Biomarker Type (Genetic, Protein) Technology (NGS, PCR, ISH, IHC) Cancer Type (Breast, Lung, Colorectal, Prostate, Leukemia) Application (Clinical, Research) End User (Pharma, Academic, CRO) – Global Foreca
Fast Guard Service Ensures the Safety of Youth Sporting Events Nationwide
When planning an event expect the unexpected, Call Fast Guard Service the nations top provider of event security. ATLANTA, March 1, 2024 /PRNewswire/ — Fast Guard Service, the nation’s leading security guard service provider for over a decade, underscores the critical need for profession
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children’s Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2
FORT LEE, N.J., March 1, 2024 /PRNewswire/ — Mezzion Pharmaceuticals is a rare disease company conducting the confirmatory pivotal phase 3 clinical trial in Fontan subjects: The Fontan Udenafil Exercise Longitudinal Assessment Trial- 2, or FUEL-2 trial. The company is pleased to announce Dr. R
Spyre Therapeutics Announces Grants of Inducement Awards
WALTHAM, Mass., March 1, 2024 /PRNewswire/ — Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches
